Physician profile
Alen Michael
NPI 1154827293
$4,086.72
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2021: $151 · 2022: $2,197 · 2023: $1,288 · 2024: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.16 |
| Travel and Lodging | $297.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,914.08 | 2022-2024 | Senza |
| Medtronic, INC. | $630.03 | 2021-2023 | Intellis Adaptivestim |
| Nalu Medical, INC. | $440.21 | 2023-2024 | Nalu Neurostimulation System |
| Si-Bone, INC. | $236.58 | 2022-2023 | |
| Boston Scientific Corporation | $232.38 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $216.28 | 2023 | Proclaim |
| Saluda Medical Americas, INC. | $167.41 | 2023 | Evoke Scs |
| Spr Therapeutics, INC | $114.47 | 2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Acacia Pharma INC | $21.94 | 2022 | |
| Avanos Medical | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alen Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.